Hamilton Lane Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
Hamilton Lane Advisors's CELL Position: Q3 2021 in Review
Hamilton Lane Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 8,789 shares — an estimated $394K sold.
Hamilton Lane Advisors first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $3.23M in Q1 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.
- Hamilton Lane Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Hamilton Lane Advisors sold 8,789 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $394K.
- Hamilton Lane Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
- Hamilton Lane Advisors's PhenomeX Inc. Common Stock position peaked at $3.23M in Q1 2021.
- 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.
Based on Hamilton Lane Advisors's 13F filing for Q3 2021, filed 14 Oct 2021.